Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 21, 2017; 23(11): 2023-2028
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2023
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2023
Figure 1 Sample endoscopic images from patients with ipilimumab-mediated enterocolitis.
A: A large, punched-out ulcer in the center of the image; B: A linear colonic ulcer; C: A segment of mild, diffuse colitis with punctate areas of erythema and colitis; D: Patchy, mild erythema. Patients from A and B had a steroid refractory course and required infliximab, while patients from C and D had steroid responsive symptoms.
- Citation: Jain A, Lipson EJ, Sharfman WH, Brant SR, Lazarev MG. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis. World J Gastroenterol 2017; 23(11): 2023-2028
- URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2023.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2023